Randomised clinical trial: Esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 2, 2012, Pages 115-125

  Sugano, K ^a   Kinoshita, Y ^b   Miwa, H ^c   Takeuchi, T ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ESOMEPRAZOLE; ETODOLAC; LOXOPROFEN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; ANOREXIA; ARTICLE; CHRONIC INFLAMMATION; CONSTIPATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; HEARTBURN; HUMAN; JAPANESE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SIDE EFFECT; STOMACH CANCER; STOMACH DISCOMFORT; TREATMENT RESPONSE; UPPER ABDOMINAL PAIN; VERTEBRAL CANAL STENOSIS; VOMITING;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DOUBLE-BLIND METHOD; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; TIME FACTORS;

EID: 84862516086     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05133.x     Document Type: Article

References (32)

1. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd,. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995; 40: 1345-50.
2. Thiefin G, Schaeverbeke T, Barthelemy P, Soufflet C, Flipo RM,. Upper gastrointestinal symptoms in patients treated with nonsteroidal anti-inflammatory drugs: prevalence and impact-the COMPLAINS study. Eur J Gastroenterol Hepatol 2010; 22: 81-7.
3. Smalley WE, Ray WA, Daugherty JR, Griffin MR,. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995; 141: 539-45.
4. Griffin MR, Ray WA, Schaffner W,. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359-63.
5. Bombardier C, Laine L, Reicin A, et al,. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-8.
6. Gabriel SE, Jaakkimainen L, Bombardier C,. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787-96.
7. Garcia Rodriguez LA, Jick H,. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72. (Pubitemid 24098698)
8. Garcia Rodriguez LA, Barreales Tolosa L,. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007; 132: 498-506. (Pubitemid 46274667)
9. Kobata Y, Yajima H, Yamao J, Tanaka Y, Fukui H, Takakura Y,. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study. Mod Rheumatol 2009; 19: 629-36.
10. Yamamoto T, Isono A, Ebato T, et al,. Prevalence of gastroduodenal mucosal injury in asymptomatic patients taking antiplatelet agents in Japan. Int J Clin Pharmacol Ther 2009; 47: 722-5.
11. Shiokawa Y, Nobunaga M, Saito T, Asaki S, Ogawa N,. Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs [in Japanese]. Ryumachi 1991; 31: 96-111.
12. Nakashima S, Arai S, Mizuno Y, et al,. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005; 21 (Suppl. 2): 60-6. (Pubitemid 40806583)
13. American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum 2008; 59: 1058-73.
14. Scheiman JM, Yeomans ND, Talley NJ, et al,. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006; 101: 701-10.
15. Hawkey CJ, Svedberg LE, Naesdal J, Byrne C,. Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies. Clin Drug Investig 2009; 29: 677-87.
16. Hawkey CJ, Talley NJ, Scheiman JM, et al,. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res Ther 2007; 9: R17.
17. Kikuchi S, Miwa H,. Efficacy of direct ELISA kit "E Plate 'Eiken' H. pylori Antibody" on diagnosis of Helicobacter pylori infection [in Japanese]. Jpn J Med Pharm Sci 2000; 43: 581-6.
18. Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A,. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988; 95: 289-94.
19. Greenwood M,. The Errors of Sampling of the Survivorship Tables. In: Reports on Public Health and Statistical Subjects. London: HMSO, 1926.
20. Miyake T, Suzaki T, Oishi M,. Correlation of gastric ulcer healing features by endoscopy, stereoscopic microscopy, and histology, and a reclassification of the epithelial regenerative process. Dig Dis Sci 1980; 25: 8-14. (Pubitemid 10132423)
21. Kimura M, Ieiri I, Mamiya K, Urae A, Higuchi S,. Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population. Ther Drug Monit 1998; 20: 243-7. (Pubitemid 28248841)
22. Sugano K, Kontani T, Katsuo S, et al,. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol 2012; 47: 540-52.
23. Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP,. Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients. Aliment Pharmacol Ther 2010; 32: 1240-8.
24. Tielemans MM, Eikendal T, Jansen JB, van Oijen MG,. Identification of NSAID users at risk for gastrointestinal complications: a systematic review of current guidelines and consensus agreements. Drug Saf 2010; 33: 443-53.
25. Huang JQ, Sridhar S, Hunt RH,. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22. (Pubitemid 34119190)
26. Sakamoto C, Sugano K, Ota S, et al,. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006; 62: 765-72. (Pubitemid 44289508)
27. Niu C-Y, Luo J-Y, Mu N-L, Wang X-Q,. Relationship between the acid-suppression efficacy of proton pump inhibitors and CYP2C19 genetic polymorphism in patients with peptic ulcer. Academic Journal of Xi'an Jiaotong University 2008; 20: 213-7.
28. Hunfeld NG, Touw DJ, Mathot RA, et al,. A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism. Aliment Pharmacol Ther 2010; 31: 150-9.
29. Sakamoto C, Soen S,. Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan. Digestion 2011; 83: 108-23.
30. Yu EW, Bauer SR, Bain PA, Bauer DC,. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med 2011; 124: 519-26.
31. Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS,. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. Can Med Assoc J 2011; 183: 310-9.
32. Kimura K, Takemoto T,. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.